Skip to content

13F-HR filed by Sofinnova Investments, Inc.

Sofinnova Investments, Inc. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 18:13:09 UTC, with 67 holding rows worth $2,301,502,546.

Accession
0001104659-26-128032
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 67 entries on the cover page, a total value of $2,301,502,546 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,301,502,546 with VALUE read as dollars as filed, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NATERA INC COM632307104Stock1,550,280$640,746,227dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share4,349,551$155,170,232dollars as filed
iShares Russell 2000 ETF464287655SHS500,000$138,945,000dollars as filedput
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock422,375$97,788,260dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK2,793,987$90,217,840dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock445,906$82,220,607dollars as filed
SEAPORT THERAPEUTICS INC81221K108COMMON STOCK3,564,871$71,903,448dollars as filed
RAPPORT THERAPEUTICS INC COM75383L102Stock1,904,408$63,988,109dollars as filed
ASTRAZENECA PLC ORDG0593M107ADR383,053$61,851,568dollars as filed
INVESCO QQQ TR46090E103COM75,000$55,482,750dollars as filedput
ARRIVENT BIOPHARMA INC04272N102COM1,696,752$51,377,651dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM534,538$50,896,036dollars as filed
Eli Lilly and Company532457108COM43,777$50,653,491dollars as filed
Bristol-Myers Squibb Company110122108COM700,000$43,680,000dollars as filedcall
DYNE THERAPEUTICS INC COM26818M108Stock2,511,006$40,452,307dollars as filed
INHIBRX BIOSCIENCES INC45720N103COM391,621$39,193,430dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock946,340$36,358,383dollars as filed
IMMUNOME INC45257U108COM1,627,469$35,006,858dollars as filed
IMMATICS N.VN44445109SHS3,585,506$31,480,743dollars as filed
NOVARTIS AG SPONSORED ADR66987V109ADR196,700$28,043,519dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock112,879$27,851,764dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM1,753,703$26,358,156dollars as filed
BIOMARIN PHARMACEUTICAL INC09061G101COM432,695$25,961,700dollars as filed
Bristol-Myers Squibb Company110122108COM329,967$20,589,941dollars as filed
Abbott Laboratories002824100COM207,000$20,457,810dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock36,491$19,774,108dollars as filed
PHARVARIS NVN69605108COMMON STOCK621,691$19,720,039dollars as filed
VERADERMICS INC922967104COMMON STOCK144,054$17,463,666dollars as filed
ANAPTYSBIO INC032724106COM330,396$16,605,703dollars as filed
BIOAGE LABS INC COM09077V100Stock2,293,788$16,262,957dollars as filed
ARCUS BIOSCIENCES INC03969F109COM626,178$16,174,178dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM396,598$16,101,879dollars as filed
IDEXX LABS INC COM45168D104Stock29,145$15,219,228dollars as filed
DISC MEDICINE INC COM254604101Stock231,628$15,162,369dollars as filed
DESIGN THERAPEUTICS INC25056L103COM1,144,827$14,390,475dollars as filed
BIOGEN INC COM09062X103Stock63,002$14,230,892dollars as filed
FIRST TRACKS BIOTHERAPEUTICS337185102ORD SHS *A*383,588$13,594,359dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK217,963$13,196,570dollars as filed
DISC MEDICINE INC COM254604101Stock200,000$13,092,000dollars as filedput
DEFINIUM THERAPEUTICS INC24477V105COM SHS339,018$12,903,025dollars as filed
NURIX THERAPEUTICS INC67080M103COMMON STOCK523,673$12,416,287dollars as filed
EDGEWISE THERAPEUTICS INC28036F105COM300,000$12,180,000dollars as filedput
ERASCA INC COM29479A108Stock677,041$9,925,421dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK150,000$9,081,750dollars as filedput
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK110,108$8,655,590dollars as filed
DAMORA THERAPEUTICS INCG2646Y104COMM STK149,197$3,174,912dollars as filed
UNIQURE NVN90064101SHS119,148$2,878,616dollars as filed
ANNEXON INC03589W102COM555,300$2,348,919dollars as filedcall
SILENCE THERAPEUTICS PLC82686Q101ADS211,802$2,314,996dollars as filed
SAVARA INC805111101COM356,224$1,838,116dollars as filed
SEPTERNA INC COM81734D104Stock46,217$1,808,471dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM19,450$1,662,586dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK162,380$1,604,314dollars as filed
PHIBRO ANIMAL HEALTH CORP (CLA71742Q106CL A COM43,216$1,544,540dollars as filed
JADE BIOSCIENCES INC008064206COM NEW107,391$1,508,844dollars as filed
NEXTCURE INC65343E207COM NEW222,654$1,115,497dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW3,703$1,078,425dollars as filed
ABSCI CORPORATION00091E109COM80,817$870,399dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A312,553$851,707dollars as filed
INVENTIVA SA46124U107ADS209,500$773,055dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK31,407$686,871dollars as filed
Wave Life Sciences Inc.94352A104COM184,825$683,853dollars as filed
AKTIS ONCOLOGY INC01021M104COMMON STOCK31,605$615,349dollars as filed
BOLT BIOTHERAPEUTICS INC097702203COM NEW137,721$506,813dollars as filed
IBIO INC451033708CMN371,700$438,606dollars as filed
LISATA THERAPEUTICS INC128058302COM156,460$225,302dollars as filed
IMAGENEBIO INC45175G207CMN31,884$146,029dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-128032this filing2026-11-16